# RiconPharma LLC – FDA Inspection, Jan 9, 2017

Source: https://www.keypedia.com/records/fda_inspections/riconpharma-llc/933e7bcc-5afa-4942-b8fc-dfe4298150e3
Source feed: FDA_Inspections

> FDA inspection 998568 of RiconPharma LLC, January 09, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 998568
- Company Name: RiconPharma LLC
- Inspection Date: 2017-01-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1344452 - 2026-09-24
- [FDA Inspection 1249674 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/riconpharma-llc/b2fe9bfd-fc81-47dd-900c-5abc6ad3efa5)
- FDA Inspection 1157388 - 2021-11-09
- FDA Inspection 1105217 - 2019-09-13
- FDA Inspection 910604 - 2015-01-21

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [FDA Associated Person](https://www.keypedia.com/people/zakaria-i-ganiyu/59c3a596-f3fc-43d9-9fa9-b763aec375d1)

Company: https://www.keypedia.com/companies/riconpharma-llc/419021d0-2e97-46b7-977f-1df932afc40b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
